期刊文献+

经皮桡动脉或肱动脉穿刺内瘘造影的应用 被引量:8

原文传递
导出
摘要 自体前臂动静脉内瘘是目前临床维持长期血液透析(血透)最常用的血管通路。但由于内瘘血管特别是流出静脉长期的穿刺、局部损伤等因素,内瘘血管可出现狭窄,导致内瘘流量不佳,甚至丧失功能,因此狭窄的早期诊断和干预对于延长内瘘的寿命十分关键。电子计算机断层扫描血管造影(CTA)评估透析患者血管通路已在临床得到广泛应用,而CTA所需对比剂量较大,同侧注入约需50~60ml,
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2011年第8期611-612,共2页 Chinese Journal of Nephrology
  • 相关文献

参考文献3

二级参考文献32

  • 1郭志勇,袁伟杰,李保春,边琪,孙莉静,潘超,崔若兰.α-酮酸配伍低蛋白饮食对腹膜透析患者残余肾功能的保护作用[J].中国血液净化,2006,5(6):304-307. 被引量:7
  • 2王陪军 萧毅 左长京.螺旋CT血管成像的原理及临床应用[A].见:景在平主编.血管腔内治疗学第1版[C].北京:人民卫生出版社,2002.95-126.
  • 3.Radiological Society of North America,Inc(RSNA)[EB/OL].http://www.radiologyinfo.org/,June11,2004.
  • 4Bargman J, Thorpe K, Churchill D. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol, 2001, 12: 2158-2162.
  • 5Shemin D, Bostom A, Laliberty P, et al. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis, 2001, 38: 85-90.
  • 6Van Biesen W, Vanholder R, Veys N, et al. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol, 2000, 11: 116-125.
  • 7Li P, Chow K-M, Wong T, et al. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. Ann Intern Med, 2003, 139: 105-112.
  • 8Suzuki H, Kanno Y, Sugahara S, et al. Effects of an angiotensin Ⅱ receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis, 2004, 43: 1056-1064.
  • 9Jassal S, Lok C, Walele A, et al. Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis. Am J Kidney Dis, 2002, 40: 178-183.
  • 10Carofei O, Galeotti P, Satriani M, et al. Clinical impact of residual function in haemodialysis. EDTNA ERCA J, 1997, 23:54-56.

共引文献58

同被引文献59

  • 1汤玉霞.1例肾动脉狭窄血管内支架成形术的病情观察与护理[J].临床护理杂志,2002,1(1):52-55. 被引量:1
  • 2李保春,陈玉,郭志勇,许静,付鹏,于光.Fogarty取栓导管在急性瘘管栓塞中的应用[J].中国血液净化,2005,4(7):361-362. 被引量:12
  • 3NKF-K/DOQI血管通路的临床实践指南[J].中国血液净化,2007,6(6):338-347. 被引量:35
  • 4Campos RP, Do Nascimento MM, Chula DC, et al. Stenosis in hemodialysis arter- iovenous fistula: evaluation and treat- ment [J]. Hemodial Int,2006,10(2): 152-161.
  • 5Kim WS, Pyun WB, Kang BC. The pri- mary patency ofpercutaneous transluminal angioplasty in hemodialysis patients withvascular access failure [J]. Korean Circ J, 2011,41(9):512-517.
  • 6Beathard GA, Arnold P, Jackson J, et al. Aggressive treatment of early fistula fail- ure [J]. kidney int,2003,64(4): 1487-1494.
  • 7Asif A, Lenz O, Merrill D, et al. Percu-taneous management of perianastomotic stenosis in arteriovenous fistulae: results of a prospective study [J]. kidney int,2006, 69(10): 1904-1909.
  • 8Hatakeyama S, Toikawa T, Okamoto A, et al. Efficacy of SMART stent placement for salvage angioplasty in hemodialysis pati- ents with recurrent vascular access sten- osis [J]. Int J Nephrol, 2011,2011:464735.
  • 9叶有新,胡为民,沈来根,冯剑,蒋欣欣,李华,应迎娟.用带切割刀扩张球囊处理动静脉内瘘狭窄[J].中华肾脏病杂志,2007,23(10):656-656. 被引量:13
  • 10Campos RP,Do Nascimento MM,Chula DC,et al.Stenosis in hemodialysis alteriovenous f istulaievaluation and treatment[J].Hemodial Int,2006,10(2):152-161.

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部